Olga Aleinikova

9.5k total citations
50 papers, 517 citations indexed

About

Olga Aleinikova is a scholar working on Hematology, Molecular Biology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Olga Aleinikova has authored 50 papers receiving a total of 517 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Hematology, 15 papers in Molecular Biology and 15 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Olga Aleinikova's work include Acute Lymphoblastic Leukemia research (14 papers), Acute Myeloid Leukemia Research (13 papers) and Immunodeficiency and Autoimmune Disorders (7 papers). Olga Aleinikova is often cited by papers focused on Acute Lymphoblastic Leukemia research (14 papers), Acute Myeloid Leukemia Research (13 papers) and Immunodeficiency and Autoimmune Disorders (7 papers). Olga Aleinikova collaborates with scholars based in Belarus, Russia and Germany. Olga Aleinikova's co-authors include Ekaterina Lukianova, Alexander A. Oraevsky, М. П. Потапнев, Dmitry Lapotko, Ursula Creutzig, Gertjan J.L. Kaspers, Martin Zimmermann, Liisa Hovi, Carmelo Rizzari and Dirk Reinhardt and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Olga Aleinikova

44 papers receiving 510 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Olga Aleinikova Belarus 11 220 133 110 99 86 50 517
Jong‐Wook Lee South Korea 16 343 1.6× 136 1.0× 84 0.8× 31 0.3× 96 1.1× 40 542
M. Sivakumaran United Kingdom 17 146 0.7× 45 0.3× 146 1.3× 77 0.8× 73 0.8× 50 694
Marcel Geyer Germany 17 49 0.2× 112 0.8× 140 1.3× 32 0.3× 87 1.0× 31 733
Rongfu Zhou China 14 258 1.2× 57 0.4× 104 0.9× 36 0.4× 142 1.7× 63 545
Hiroyuki Ueda Japan 14 47 0.2× 77 0.6× 104 0.9× 46 0.5× 24 0.3× 24 784
Aiming Pang China 13 259 1.2× 66 0.5× 109 1.0× 24 0.2× 79 0.9× 103 573
Caroline O’Brien United States 12 175 0.8× 47 0.4× 67 0.6× 72 0.7× 171 2.0× 25 556
Serena Perna Italy 17 63 0.3× 31 0.2× 233 2.1× 194 2.0× 523 6.1× 49 1.1k
Tatsuyuki Hayashi Japan 10 196 0.9× 31 0.2× 91 0.8× 110 1.1× 155 1.8× 16 516
Yasuhiko Fujii Japan 14 202 0.9× 14 0.1× 135 1.2× 53 0.5× 25 0.3× 39 939

Countries citing papers authored by Olga Aleinikova

Since Specialization
Citations

This map shows the geographic impact of Olga Aleinikova's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Olga Aleinikova with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Olga Aleinikova more than expected).

Fields of papers citing papers by Olga Aleinikova

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Olga Aleinikova. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Olga Aleinikova. The network helps show where Olga Aleinikova may publish in the future.

Co-authorship network of co-authors of Olga Aleinikova

This figure shows the co-authorship network connecting the top 25 collaborators of Olga Aleinikova. A scholar is included among the top collaborators of Olga Aleinikova based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Olga Aleinikova. Olga Aleinikova is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Попов, А. М., Günter Henze, Grigory Tsaur, et al.. (2023). A Single Dose of PEG-Asparaginase at the Beginning of Induction Not Only Accelerates MRD Clearance but Also Improves Long-Term Outcome in Children with B-Lineage ALL. Cancers. 15(23). 5547–5547. 2 indexed citations
3.
Aleinikova, Olga, et al.. (2022). Phenotypic and functional characterisation of locally produced natural killer cells ex vivo expanded with the K562-41BBL-mbIL21 cell line. Clinical and Experimental Medicine. 23(6). 2551–2560. 4 indexed citations
4.
Aleinikova, Olga, et al.. (2022). BENCHMARKING AS AN IMPORTANT METHOD FOR THE DEVELOPMENT OF THE HEALTH CARE SYSTEM ON THE «CHILDREN’S ONCOLOGY AND HEMATOLOGY» PROFILE MODEL. PEDIATRIA Journal named after G N SPERANSKY. 101(3). 142–148. 2 indexed citations
5.
Hill, A V, et al.. (2021). Comparative study of prophylaxis with high and low doses of voriconazole in children with malignancy. Current Medical Mycology. 6(4). 27–34. 2 indexed citations
6.
7.
Sharapova, Svetlana, Emma Haapaniemi, Inga Sakovich, et al.. (2019). Heterozygous activating mutation in RAC2 causes infantile-onset combined immunodeficiency with susceptibility to viral infections. Clinical Immunology. 205. 1–5. 21 indexed citations
8.
9.
Sharapova, Svetlana, Irina Kondratenko, Larysa Kostyuchenko, et al.. (2015). Molecular Characteristics, Clinical and Immunologic Manifestations of 11 Children with Omenn Syndrome in East Slavs (Russia, Belarus, Ukraine). Journal of Clinical Immunology. 36(1). 46–55. 7 indexed citations
10.
Aleinikova, Olga, Alina Fedorova, & Svetlana Sharapova. (2015). Should Allogeneic Hematopoietic Stem Cell Transplantation be a Treatment Option for Patients with Nijmegen Breakage Syndrome? Belarusian Experience. 4(1-2). 31–37. 3 indexed citations
11.
Aleinikova, Olga, et al.. (2014). Quantitative analysis of chimerism after allogeneic hematopoietic stem cell transplantation with molecular genetic methods. SHILAP Revista de lepidopterología. 1 indexed citations
12.
Aleinikova, Olga, et al.. (2014). RUNX1T1/MTG8/ETO gene expression status in human t(8;21)(q22;q22)-positive acute myeloid leukemia cells. Leukemia Research. 38(9). 1102–1110. 10 indexed citations
13.
Kaspers, Gertjan J.L., Martin Zimmermann, Dirk Reinhardt, et al.. (2013). Improved Outcome in Pediatric Relapsed Acute Myeloid Leukemia: Results of a Randomized Trial on Liposomal Daunorubicin by the International BFM Study Group. Journal of Clinical Oncology. 31(5). 599–607. 152 indexed citations
14.
Aleinikova, Olga, et al.. (2011). AML1/RUNX1 gene point mutations in childhood myeloid malignancies. Pediatric Blood & Cancer. 57(4). 583–587. 11 indexed citations
15.
Kaspers, Gertjan J.L., Martin Zimmermann, Dirk Reinhardt, et al.. (2010). Central Nervous System (CNS) Involvement In Pediatric Relapsed Acute Myeloid Leukemia: Results and Lessons From Study Relapsed AML 2001/01. Blood. 116(21). 184–184. 2 indexed citations
16.
Krasko, О. V., et al.. (2009). Прогностическое значение минимальной остаточной болезни для безрецидивной выживаемости детей с острым лимфобластным лейкозом на протоколе ОЛЛ-МБ-2002 (однофакторный и многофакторный анализ). Oncohematology. 1 indexed citations
17.
Aleinikova, Olga, et al.. (2009). [Role of three-color flow cytofluorometry in the algorithm for detection of minimal residual disease in children with acute lymphoblastic and acute myeloblastic leukemia].. PubMed. 15–8. 1 indexed citations
18.
Aleinikova, Olga, et al.. (2007). Apoptosis and proliferation differences between CD34+ and CD34– leukemic subpopulations in childhood acute leukemia. Hematology. 12(5). 403–407. 5 indexed citations
19.
Потапнев, М. П., et al.. (2006). Study of expression and functional activity of P-GP membrane glycoprotein in children with acute leukemia. Bulletin of Experimental Biology and Medicine. 141(6). 727–730. 3 indexed citations
20.
Stasevich, Irina, et al.. (2006). Translocation (10;11)(p12;q23) in childhood acute myeloid leukemia: incidence and complex mechanism. Cancer Genetics and Cytogenetics. 169(2). 114–120. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jong‐Wook Lee Breakdown of academic impact, for papers by M. Sivakumaran Breakdown of academic impact, for papers by Marcel Geyer Breakdown of academic impact, for papers by Rongfu Zhou Breakdown of academic impact, for papers by Hiroyuki Ueda Breakdown of academic impact, for papers by Aiming Pang Breakdown of academic impact, for papers by Caroline O’Brien Breakdown of academic impact, for papers by Serena Perna Breakdown of academic impact, for papers by Tatsuyuki Hayashi Breakdown of academic impact, for papers by Yasuhiko Fujii
Rankless by CCL
2026